skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,171) Views

Editor in Chief Dr Roger M Pinder

1176-6328


Letter: NEURON – a network of European funding organizations ||FREE PAPER||
Marlies Dorlöchter and Hella Lichtenberg
Neuropsychiatric Disease and Treatment 2005, 1:87-88
09 May 2005


MRI parameters of Alzheimer’s disease in an Arab population of Wadi Ara, Israel
Abdalla Bowirrat, Irith I Reider-Groswasser, Marlene Oscar-Berman, Orna Aizenstein, Gad Levy, Amos D Korczyn
Neuropsychiatric Disease and Treatment 2005, 1:77-85
18 February 2005


Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer’s type in an elderly Arab population in Wadi Ara, Israel
Abdalla Bowirrat, Jing Cui, Kristin Waraska, Robert P Friedland, Marlene Oscar-Berman, Lindsay A Farrer, Amos Korczyn, Clinton T Baldwin
Neuropsychiatric Disease and Treatment 2005, 1:73-76
18 February 2005


Stress-induced increases in avoidance responding: an animal model of posttraumatic stress disorder behavior?
Francis X Brennan, Kevin D Beck, Richard J Ross, Richard J Servatius
Neuropsychiatric Disease and Treatment 2005, 1:69-72
18 February 2005


Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients.
Francis Lavergne, Ivan Berlin, Alex Gamma, Hans Stassen, Jules Angst
Neuropsychiatric Disease and Treatment 2005, 1:59-68
18 February 2005


What moderator characteristics are associated with better prognosis for depression?
Madhukar H Trivedi, David W Morris, Ji-Yang Pan, Bruce D Grannemann, A John Rush
Neuropsychiatric Disease and Treatment 2005, 1:51-57
18 February 2005


Mild cognitive impairment in Parkinson’s disease: the challenge and the promise || FREE PAPER ||
Hubert H Fernandez, Gregory P Crucian, Michael S Okun, Catherine C Price, Dawn Bowers
Neuropsychiatric Disease and Treatment 2005, 1:37-50
18 February 2005


Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.
Francis E Lotrich, Bruce G Pollock
Neuropsychiatric Disease and Treatment 2005, 1:17-35
18 February 2005


Affect regulation: a systems neuroscience perspective.
Mani N Pavuluri, Ellen S Herbener, John A Sweeney
Neuropsychiatric Disease and Treatment 2005, 1:9-15
18 February 2005


Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
Roger M Pinder
Neuropsychiatric Disease and Treatment 2005, 1:3-7
18 February 2005


Editorial Foreword || FREE PAPER ||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2005, 1:1-1
08 May 2005